首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1683666

全球體外診斷市場研究報告-產業分析、規模、佔有率、成長、趨勢與預測 2025 年至 2033 年

Global In Vitro Diagnostics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 252 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球體外診斷市場規模預計將從 2024 年的 896.4 億美元成長到 2033 年的 1,261.6 億美元，在 2026 年至 2033 年的預測期內呈現 3.87% 的強勁年複合成長率(CAGR)。

隨著慢性病發病率不斷上升以及對早期準確診斷解決方案的需求不斷成長，體外診斷（IVD）市場有望大幅成長。 IVD 測試是對血液、尿液和組織等樣本進行的，在疾病檢測、監測和管理中發揮關鍵作用。隨著醫療保健提供者越來越重視個人化醫療和預防保健，對先進 IVD 技術的需求預計將上升。分子診斷、即時診斷和自動化方面的創新正在提高診斷過程的準確性和效率，進一步推動市場成長。

IVD技術的進步也正在塑造這個市場的未來。快速測試方法的發展以及人工智慧和機器學習在資料分析中的整合正在徹底改變診斷的方式。這些創新使醫療保健專業人員能夠及時獲得結果，促進更快地做出決策並改善患者的治療效果。此外，由於患者尋求方便、易於獲得的診斷解決方案，家庭檢測和遠距醫療的成長趨勢可能會對 IVD 市場產生正面影響。

此外，新興經濟體醫療保健基礎設施的擴張預計將對體外診斷市場產生積極影響。隨著亞太、拉丁美洲等地區醫療保健條件的改善和對優質診斷服務的需求增加，IVD產品的消費量將會上升。專注於開發滿足特定區域需求的創新且具有成本效益的診斷解決方案的公司將佔據有利地位以佔領市場佔有率。隨著 IVD 市場的發展，技術進步、監管變化和消費者偏好轉變的相互作用將創造一個充滿成長和創新機會的動態環境。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業趨勢
波特五力分析
市場吸引力分析
- 市場吸引力分析：按產品類型
- 依技術進行市場吸引力分析
- 市場吸引力分析：按應用
- 最終用戶的市場吸引力分析
- 市場吸引力分析：按地區

第4章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料製造商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球體外診斷市場分析：依產品類型

概覽：依產品類型
歷史與預測資料分析：按產品類型
儀器
試劑
軟體
服務

第 6 章：全球體外診斷市場分析：按技術

技術概覽
按技術進行的歷史和預測數據分析
免疫分析
臨床化學
分子診斷
血液學
微生物學
凝血
其他

第 7 章：全球體外診斷市場分析：按應用

概述：按應用
歷史和預測數據分析：按應用
傳染病
腫瘤學
心臟病學
腎臟病學
自體免疫疾病
其他

第 8 章：全球體外診斷市場分析：依最終用戶

最終用戶概覽
最終用戶的歷史和預測數據分析
醫院
診斷實驗室
學術及研究機構
其他

第 9 章：全球體外診斷市場分析：按地區分類

區域展望
介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第 10 章：體外診斷公司的競爭格局

體外診斷市場競爭
夥伴關係/合作/協議
合併與收購
新產品發布
其他進展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Roche Diagnostics

公司概況
公司收入
產品
最新動態

Abbott Laboratories

公司概況
公司收入
產品
最新動態

Siemens Healthineers

公司概況
公司收入
產品
最新動態

Danaher Corporation

公司概況
公司收入
產品
最新動態

Thermo Fisher Scientific

公司概況
公司收入
產品
最新動態

Becton

公司概況
公司收入
產品
最新動態

Dickinson And Company (BD)

公司概況
公司收入
產品
最新動態

Bio-Rad Laboratories

公司概況
公司收入
產品
最新動態

BioMAfA(C)Rieux

公司概況
公司收入
產品
最新動態

Qiagen

公司概況
公司收入
產品
最新動態

Hologic

公司概況
公司收入
產品
最新動態

Sysmex Corporation

公司概況
公司收入
產品
最新動態

Ortho Clinical Diagnostics

公司概況
公司收入
產品
最新動態

Agilent Technologies

公司概況
公司收入
產品
最新動態

Illumina"

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

簡介目錄圖表

Product Code: VMR11218520

Global In Vitro Diagnostics Market size is anticipated to grow from USD 89.64 Billion in 2024 to USD 126.16 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 3.87% during the forecast period of 2026 to 2033.

The in vitro diagnostics (IVD) market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and the rising demand for early and accurate diagnostic solutions. IVD tests, which are performed on samples such as blood, urine, and tissue, play a critical role in disease detection, monitoring, and management. As healthcare providers increasingly prioritize personalized medicine and preventive care, the demand for advanced IVD technologies is expected to rise. Innovations in molecular diagnostics, point-of-care testing, and automation are enhancing the accuracy and efficiency of diagnostic processes, further propelling market growth.

Technological advancements in IVD are also shaping the future of this market. The development of rapid testing methods and the integration of artificial intelligence and machine learning in data analysis are revolutionizing the way diagnostics are performed. These innovations enable healthcare professionals to obtain timely results, facilitating quicker decision-making and improved patient outcomes. Additionally, the growing trend towards home-based testing and telemedicine is likely to influence the IVD market positively, as patients seek convenient and accessible diagnostic solutions.

Moreover, the expansion of healthcare infrastructure in emerging economies is expected to positively impact the in vitro diagnostics market. As access to healthcare improves and the demand for quality diagnostic services increases in regions such as Asia-Pacific and Latin America, the consumption of IVD products will rise. Companies that focus on developing innovative and cost-effective diagnostic solutions tailored to specific regional needs will be well-positioned to capture market share. As the IVD market evolves, the interplay of technological advancements, regulatory changes, and shifting consumer preferences will create a dynamic environment ripe with opportunities for growth and innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

Instruments
Reagents
Software
Services

By Technology

Immunoassay
Clinical Chemistry
Molecular Diagnostics
Hematology
Microbiology
Coagulation
Others

By Application

Infectious Diseases
Oncology
Cardiology
Nephrology
Autoimmune Diseases
Others

By End-User

Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Others
COMPANIES PROFILED
Roche Diagnostics
Abbott Laboratories
Siemens Healthineers
Danaher Corporation
Thermo Fisher Scientific
Becton
Dickinson and Company (BD)
Bio-Rad Laboratories
bioMA(C)rieux
Qiagen
Hologic
Sysmex Corporation
Ortho Clinical Diagnostics
Agilent Technologies
Illumina"
The above list can be customized.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. IN VITRO DIAGNOSTICS INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-User
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Instruments Historic and Forecast Sales By Regions
5.4. Reagents Historic and Forecast Sales By Regions
5.5. Software Historic and Forecast Sales By Regions
5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data Analysis By Technology
6.3. Immunoassay Historic and Forecast Sales By Regions
6.4. Clinical Chemistry Historic and Forecast Sales By Regions
6.5. Molecular Diagnostics Historic and Forecast Sales By Regions
6.6. Hematology Historic and Forecast Sales By Regions
6.7. Microbiology Historic and Forecast Sales By Regions
6.8. Coagulation Historic and Forecast Sales By Regions
6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data Analysis By Application
7.3. Infectious Diseases Historic and Forecast Sales By Regions
7.4. Oncology Historic and Forecast Sales By Regions
7.5. Cardiology Historic and Forecast Sales By Regions
7.6. Nephrology Historic and Forecast Sales By Regions
7.7. Autoimmune Diseases Historic and Forecast Sales By Regions
7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY END-USER

8.1. Overview By End-User
8.2. Historical and Forecast Data Analysis By End-User
8.3. Hospitals Historic and Forecast Sales By Regions
8.4. Diagnostic Laboratories Historic and Forecast Sales By Regions
8.5. Academic and Research Institutes Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE IN VITRO DIAGNOSTICS COMPANIES

10.1. In Vitro Diagnostics Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF IN VITRO DIAGNOSTICS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Roche Diagnostics
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Abbott Laboratories
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Siemens Healthineers
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Danaher Corporation
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Thermo Fisher Scientific
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Becton
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Dickinson And Company (BD)
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Bio-Rad Laboratories
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. BioMAfA(C)Rieux
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Qiagen
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Hologic
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Sysmex Corporation
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. Ortho Clinical Diagnostics
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments
11.16. Agilent Technologies
- 11.16.1 Company Overview
- 11.16.2 Company Revenue
- 11.16.3 Products
- 11.16.4 Recent Developments
11.17. Illumina"
- 11.17.1 Company Overview
- 11.17.2 Company Revenue
- 11.17.3 Products
- 11.17.4 Recent Developments